Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | MYC | P01106 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | TPMT | P51580 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7693802 | 0.81 | CA12 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16627110 | 0.81 | TDP1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL265366 | 0.79 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL394178 | 0.79 | TDP1 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13307515 | 0.77 | CA12 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27613494 | 0.77 | TPMT (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL23817425 | 0.76 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4859473 | 0.75 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14107663 | 0.74 | SERPINE1 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2652364 | 0.74 | LMNA (0.58) | TDP1ALDH1A1LMNAL3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160235866-A1 | MRI CONTRAST AGENTS FOR CELL LABELING | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-08-18 | — | — | US | disclosed |
| US-20160235866-A1 | MRI CONTRAST AGENTS FOR CELL LABELING | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-08-18 | — | — | US | disclosed |
| WO-2015048912-A1 | MRI CONTRAST AGENTS FOR CELL LABELING | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2015-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160235866-A1 | MRI CONTRAST AGENTS FOR CELL LABELING | MPI, HMBS, TSPO | CA12 833/4885CA1 525/4885CA2 856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.